Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
277,563,973
-
Total 13F shares
-
59,769,581
-
Share change
-
-2,364,122
-
Total reported value
-
$89,652,255
-
Put/Call ratio
-
142%
-
Price per share
-
$1.50
-
Number of holders
-
79
-
Value change
-
-$6,217,381
-
Number of buys
-
39
-
Number of sells
-
29
Institutional Holders of Invivyd, Inc. - Common Stock, $0.0001 par value per share (IVVD) as of Q4 2022
As of 31 Dec 2022,
Invivyd, Inc. - Common Stock, $0.0001 par value per share (IVVD) was held by
79 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
59,769,581 shares.
The largest 10 holders included
FMR LLC, M28 Capital Management LP, Alphabet Inc., ORBIMED ADVISORS LLC, BlackRock Inc., Slate Path Capital LP, 683 Capital Management, LLC, VANGUARD GROUP INC, Bain Capital Life Sciences Investors, LLC, and Redmile Group, LLC.
This page lists
80
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.